CompletedPhase 3

Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Iran31 participantsStarted 2005-11

Plain-language summary

To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Cases with subfoveal or juxtafoveal CNV due to a non-AMD related cause. Exclusion Criteria: * Evidence of AMD

What they're measuring

Visual acuity

Timeframe: 6 months

Trial details

NCT IDNCT00370786

SponsorShahid Beheshti University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-11

View on ClinicalTrials.gov More Choroidal Neovascularization trials